LAE-102
LAE-102, a monoclonal antibody, is an activin receptor type II-A (ACTRIIA/ACVR2) antagonist. LAE-102 is promising for research of endocrine and metabolic diseases, tumors, and respiratory system diseases[1].
Product Specifications
UNSPSC
12352203
Target
Anaplastic lymphoma kinase (ALK) ; TGF-beta/Smad; TGF-β Receptor
Related Pathways
Protein Tyrosine Kinase/RTK; Stem Cell/Wnt; TGF-beta/Smad
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Endocrinology; Metabolic Disease
Purity
99.46
Smiles
[LAE-102]
Molecular Weight
(144.92 kDa)
References & Citations
[1]https://synapse.zhihuiya.com/drug/900ddb627c6a4b1a88d3f4ef37e15c1c
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2534205 3x 1.0 µg
TRNAY16P sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 
D3795-02A-AP 200 µL
DKK3, CT (Dickkopf-related Protein 3, Dickkopf-3, Dkk-3, REIC, NQ258/PRO295) (AP) discontinued
Sign In for Pricing
View Details